Scarica l'app Stockscreener
1.67
0.00%
0.00
Dopo l'orario di chiusura:
1.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.67
Aprire:
$1.73
Volume 24 ore:
39,782
Relative Volume:
0.18
Capitalizzazione di mercato:
$19.33M
Reddito:
$996.00K
Utile/perdita netta:
$-6.09M
Rapporto P/E:
-3.1509
EPS:
-0.53
Flusso di cassa netto:
$-9.76M
1 W Prestazione:
-9.24%
1M Prestazione:
+8.44%
6M Prestazione:
+54.63%
1 anno Prestazione:
+51.82%
Intervallo 1D:
$1.64
$1.74
Intervallo di 1 settimana:
$1.62
$1.86
Portata 52W:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Nome
Therapeuticsmd Inc
Settore
Telefono
561-961-1900
Indirizzo
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Confronta TXMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.67 | 19.33M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
122.76 | 53.87B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.83 | 45.71B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.32 | 34.49B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
507.00 | 22.00B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-08-07 | Downgrade | Jefferies | Hold → Underperform |
| 2020-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Iniziato | Guggenheim | Buy |
| 2019-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-30 | Ripresa | Noble Capital Markets | Outperform |
| 2018-06-15 | Iniziato | JP Morgan | Overweight |
| 2017-09-08 | Iniziato | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Ripresa | Jefferies | Buy |
| 2016-11-22 | Iniziato | Oppenheimer | Outperform |
| 2016-11-07 | Ripresa | Guggenheim | Buy |
| 2016-04-04 | Iniziato | Goldman | Buy |
| 2015-12-08 | Reiterato | Jefferies | Buy |
| 2015-12-08 | Reiterato | Stifel | Buy |
| 2015-09-21 | Reiterato | Jefferies | Buy |
| 2015-06-09 | Iniziato | Guggenheim | Buy |
| 2014-07-08 | Iniziato | FBR Capital | Outperform |
| 2014-04-17 | Reiterato | Noble Financial | Buy |
| 2014-01-28 | Reiterato | Noble Financial | Buy |
Mostra tutto
Therapeuticsmd Inc Borsa (TXMD) Ultime notizie
Why hedge funds are buying TherapeuticsMD Inc. stock2025 Key Lessons & Safe Swing Trade Setups - Улправда
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Approves Key Proposals at Annual Meeting - TipRanks
TherapeuticsMD (NASDAQ: TXMD) investors approve 2025 votes, 640M share authorization - Stock Titan
Price to earnings ratio of TherapeuticsMD, Inc. – DUS:29TA - TradingView — Track All Markets
29TA Stock Price and Chart — DUS:29TA - TradingView — Track All Markets
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
Dip Buying: Is TherapeuticsMD Inc stock attractive for income investorsIPO Watch & AI Based Trade Execution Alerts - moha.gov.vn
With TherapeuticsMD Stock Surging, Have You Considered The Downside? - Trefis
TherapeuticsMD (TXMD) Stock Analysis Report | Financials & Insights - Benzinga
TherapeuticsMD, Inc. (TXMD) -6.3% in After-hours: Price Decline Despite Recent Results - Stocks Telegraph
Will TherapeuticsMD Inc. (29TA) stock profit from automation waveEarnings Miss & Weekly Watchlist of Top Performers - Newser
Will TherapeuticsMD Inc. (29TA) stock sustain bullish trend into 2025Trade Risk Summary & Safe Entry Zone Identification - Newser
Can TherapeuticsMD Inc. (29TA) stock test all time highsJuly 2025 Setups & Step-by-Step Trade Execution Guides - Newser
Is TherapeuticsMD Inc. stock affected by interest rate hikes - Newser
TherapeuticsMD Inc. Stock Sheds 3.9%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
TherapeuticsMD Announces Pricing of Offering of Common Stock - AOL.com
TherapeuticsMD, Inc. (TXMD) 5.48% in After-hours: What’s Driving the Move? - Stocks Telegraph
TherapeuticsMD Inc Stock Analysis and ForecastCandlestick Trading Patterns & Low Risk Trading Plans - earlytimes.in
TherapeuticsMD Inc. Stock Falls 7.9%, Underperforms Market - 富途牛牛
What drives TherapeuticsMD Inc 29TA stock priceSupport Zone Identification & High Return Stock Ideas - earlytimes.in
Is TherapeuticsMD Inc. stock a buy before product launchesWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Is TherapeuticsMD Inc. (29TA) stock supported by strong fundamentalsAnalyst Downgrade & Expert Curated Trade Ideas - newser.com
Can TherapeuticsMD Inc. stock hit analyst price targets2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
Will TherapeuticsMD Inc. (29TA) stock outperform energy sector in 2025Portfolio Update Summary & AI Enhanced Trading Signals - newser.com
Will TherapeuticsMD Inc. (29TA) stock hit Wall Street targetsPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
How TherapeuticsMD Inc. (29TA) stock responds to bond marketMarket Volume Summary & Consistent Return Investment Signals - newser.com
Why TherapeuticsMD Inc. stock is seen as undervaluedQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
Trend analysis for TherapeuticsMD Inc. this week2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - newser.com
How TherapeuticsMD Inc. (29TA) stock compares with tech leadersGap Up & Community Consensus Stock Picks - newser.com
Is TherapeuticsMD Inc. (29TA) stock a contrarian opportunityMarket Performance Report & Reliable Breakout Forecasts - newser.com
Therapeuticsmd Inc Azioni (TXMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
12.55%
0.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):